Novo Nordisk A/S ADR buy StockNews.com
Start price
14.12.24
/
50%
€102.50
Target price
14.12.25
-
Performance (%)
-58.15%
End price
15.12.25
€42.90
Summary
This prediction ended on 15.12.25 with a price of €42.90. Massive losses of -58.15% were the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Novo Nordisk A/S ADR where he still thinks Novo Nordisk A/S ADR is a Buy. A total of €1.10 was paid as dividends for this prediction. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | -2.879% | -2.879% | -55.975% |
| iShares Core DAX® | -2.117% | -7.974% | -1.733% |
| iShares Nasdaq 100 | -1.323% | -0.066% | 16.602% |
| iShares Nikkei 225® | -0.324% | -6.382% | 25.629% |
| iShares S&P 500 | -1.568% | -1.965% | 10.831% |
Comments by StockNews_com for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten